These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38904370)

  • 41. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
    Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
    Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unveiling the complexity of rifampicin drug susceptibility testing in
    Qadir M; Khan MT; Khan SA; Akram M; Canseco JO; Faryal R; Wei DQ; Tahseen S
    J Med Microbiol; 2024 Sep; 73(9):. PubMed ID: 39229883
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of the MeltPro TB assay and whole-genome sequencing assay for rapid molecular diagnosis of drug resistant tuberculosis in guangdong province.
    Yu M; Zhang C; Xu L; Peng K; Qiu H; Zhuo W; Zhao Y; Wu Z; Chen X; Chen Y; Liao Q; Huang Y; Wei W
    Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116128. PubMed ID: 38007912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
    Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
    [No Abstract]   [Full Text] [Related]  

  • 45. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
    Gliddon HD; Frampton D; Munsamy V; Heaney J; Pataillot-Meakin T; Nastouli E; Pym AS; Steyn AJC; Pillay D; McKendry RA
    Microbiol Spectr; 2021 Dec; 9(3):e0061021. PubMed ID: 34817282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment.
    Zhang G; Sun X; Fleming J; Ran F; Luo J; Chen H; Ju H; Wang Z; Zhao H; Wang C; Zhang F; Dai X; Yang X; Li C; Liu Y; Wang Y; Zhang X; Jiang Y; Wu Z; Bi L; Zhang H
    Clin Microbiol Infect; 2024 May; 30(5):637-645. PubMed ID: 38286176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.
    van Beek J; Haanperä M; Smit PW; Mentula S; Soini H
    Clin Microbiol Infect; 2019 Jan; 25(1):82-86. PubMed ID: 29653190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant
    Chong Y; Li X; Long Y; Pei S; Ren Q; Feng F; Zhang H
    Microbiol Spectr; 2024 Jun; 12(6):e0393023. PubMed ID: 38687077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report.
    Katale BZ; Rofael S; Elton L; Mbugi EV; Mpagama SG; Mtunga D; Mafie MG; Mbelele PM; Williams C; Mvungi HC; Williams R; Saku GA; Ruta JA; McHugh TD; Matee MI
    Ann Clin Microbiol Antimicrob; 2024 Aug; 23(1):76. PubMed ID: 39175078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
    García-Marín AM; Cancino-Muñoz I; Torres-Puente M; Villamayor LM; Borrás R; Borrás-Máñez M; Bosque M; Camarena JJ; Colomer-Roig E; Colomina J; Escribano I; Esparcia-Rodríguez O; Gil-Brusola A; Gimeno C; Gimeno-Gascón A; Gomila-Sard B; González-Granda D; Gonzalo-Jiménez N; Guna-Serrano MR; López-Hontangas JL; Martín-González C; Moreno-Muñoz R; Navarro D; Navarro M; Orta N; Pérez E; Prat J; Rodríguez JC; Ruiz-García MM; Vanaclocha H; ; González-Candelas F; Furió V; Comas I
    Lancet Microbe; 2024 Jan; 5(1):e43-e51. PubMed ID: 38061383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Aung HL; Tun T; Moradigaravand D; Köser CU; Nyunt WW; Aung ST; Lwin T; Thinn KK; Crump JA; Parkhill J; Peacock SJ; Cook GM; Hill PC
    J Glob Antimicrob Resist; 2016 Sep; 6():113-117. PubMed ID: 27530852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.